The company, which has a U.S. office, is officially opposed to the death penalty. Lundbeck is the only company that still manufactures pentobarbital for purchase in the United States, according to the report. While Lundbeck is against its use as part of a death penalty cocktail, it wants to continue providing the product to patients who need it.
Physicians have written to the company urging it not to withdraw pentobarbital. In turn, Lundbeck has sent letters to prisons in 11 states demanding they stop using the drug in lethal injection.
Read the GlobalPost report on Lundbeck’s production of pentobarbital.
Related Articles on Anesthesia:
Board of New York’s Orange Regional Medical Center Welcomes Dr. Lon J. Merin
4 Strategies to Manage the Drug Shortage From Dr. John Dombrowski
Pharmacists, Physicians Try to Cope With Drug Shortages
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
